Search

everythinglearnresearchcommunity

for

Search:↓

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

A combined drug and laser treatment improved hirsutism in a PCOS patient, also enhancing her heart health and requiring regular liver and kidney checks.

Young women with PCOS without additional risk factors may have normal heart function.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Keratin is crucial for keeping skin cells healthy and its changes can lead to diseases and affect cell behavior.

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.